DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Topiroxostat
Topiroxostat
Specifications of Approved Drug Compound Library
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
Cross-Over Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease (TROFEO Trial)
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Report on the Deliberation Results May 8, 2013 Evaluation And
Metrochem API Private Limited
Protective Effects of Topiroxostat on an Ischemia-Reperfusion Model of Rat Hearts
“M/S. AJANTA PHARMA LTD.”
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Detailed Program and Abstracts
Jasvinder Singh, MD
Management of Hyperuricemia & Gouty Arthritis with Unani Murakkab
Effects, Safety, and Plasma Levels of Topiroxostat and Its Metabolites In
Efficacy and Safety of Dotinurad in Hyperuricemic Patients with Or Without Gout: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cphi China-Apis, Intermediates & Fine Chemicals.Xlsx
The Influence of Albumin on the Plasma
Pharmaceuticals and Medical Devices Safety In- Formation No
Top View
Report on Investigation Results June 20, 2019 Pharmaceuticals And
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: an Evidence-Based Update
Influence of Xanthine Oxidoreductase Inhibitor, Topiroxostat, on Body
Bicyclic-Fused Heteroaryl Or Aryl Compounds and Their
Free PDF Download
Aozeal€Stock€Products 2021.06.01 (1).Xlsx
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Įsakymas
Certificate of Analysis
I Ha Un Torn Datuk Umum Mundial Month
Effects on Uric Acid Metabolism of the Drugs Except the Antihyperuricemics
Topomer Comfa Analysis of Xanthine Oxidase Inhibitors
210311 Wild Guided Report.Indd
WO 2015/150995 Al 8 October 2015 (08.10.2015) P O P C T
(2) Patent Application Publication (10) Pub. No.: US 2016/0354315 A1 Li (43) Pub
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Hypouricemic Agents Reduce Indoxyl Sulfate Excretion by Inhibiting The
List of Impurity Products
Topiroxostat Showed Renoprotection Via Various Mechanisms Including
Who Want a La Unitate Un Man At
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
THE PHARMACEUTICALS and MEDICAL DEVICES AGENCY ANNUAL REPORT FY 2013 (April 2013 - March 2014)
Hyperuricemia Resistant to a Xanthine Oxidase Inhibitor, Topiroxostat: a Case Report
New Drugs Approved in FY 2013
Drug Repurposing Compound Library (96-Well)
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor S
Review Final
Download Product Insert (PDF)
Cphi & P-MEC China Exhibition List展商名单version版本20170609
Electrochemical Analysis of Uric Acid Excretion to the Intestinal Lumen: Effect of Serum Uric Acid-Lowering Drugs and 5/6 Nephrectomy on Intestinal Uric Acid Levels
The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Comparative Study Between Febuxostat and Allupurinol Based on Safety and Urate-Lowering Efficacy in Gout Patients of Indian Population
Identification of Febuxostat As a New Strong ABCG2 Inhibitor
Rev Iss Web Jcpt 12391 41-3 290..297